about
Disease progression and search for monogenic diabetes among children with new onset type 1 diabetes negative for ICA, GAD- and IA-2 Antibodies.The PTPN22 C1858T gene variant is associated with proinsulin in new-onset type 1 diabetes.Complex multi-block analysis identifies new immunologic and genetic disease progression patterns associated with the residual β-cell function 1 year after diagnosis of type 1 diabetes.Disease progression among 446 children with newly diagnosed type 1 diabetes located in Scandinavia, Europe, and North America during the last 27 yr.Variation within the PPARG gene is associated with residual beta-cell function and glycemic control in children and adolescents during the first year of clinical type 1 diabetes.Association between autoantibodies to the Arginine variant of the Zinc transporter 8 (ZnT8) and stimulated C-peptide levels in Danish children and adolescents with newly diagnosed type 1 diabetes.Partial remission definition: validation based on the insulin dose-adjusted HbA1c (IDAA1C) in 129 Danish children with new-onset type 1 diabetes.[Prenatal diagnosis of congenital insulin-resistant diabetes (Donohue's syndrome)].The influence of glucagon on postprandial hyperglycaemia in children 5 years after onset of type 1 diabetesRelationship between ZnT8Ab, theSLC30A8gene and disease progression in children with newly diagnosed type 1 diabetesMeal-Stimulated Glucagon Release Is Associated with Postprandial Blood Glucose Level and Does Not Interfere with Glycemic Control in Children and Adolescents with New-Onset Type 1 DiabetesCo-localisation of the Kir6.2/SUR1 channel complex with glucagon-like peptide-1 and glucose-dependent insulinotrophic polypeptide expression in human ileal cells and implications for glycaemic control in new onset type 1 diabetes
P50
Q33700991-D4712861-94A4-4658-B2DD-6DC7E87A4753Q33853306-C400C77F-1135-47A4-9A30-1EEA041308A1Q34765755-D0324484-BAC4-45DF-A6D4-72913D6392ACQ46443792-6B246F16-36F8-41A6-8B9D-D66D2E8AA2E3Q46605248-D5F81B48-65B6-4525-B156-C03AB709ABD4Q50556599-FF267207-BEDA-4C14-8BF8-DD7D79AE2475Q50562673-49D8754D-3376-47D6-91BF-106F288F033DQ52577623-11BF1860-84C6-4D6A-950F-0DEE1D4E4D73Q57637770-D9B324FD-15DE-44D7-974F-9C239482A91FQ58201161-0BBB3F18-C08E-468E-842A-3FEB0B2D7983Q58224383-B177E2E3-1939-4793-882F-75BB3709A502Q58224395-A23EAAEE-E047-4D50-B2C8-CC75AC18BC87
P50
description
researcher ORCID ID = 0000-0003-1868-356X
@en
wetenschapper
@nl
name
Sven Pörksen
@ast
Sven Pörksen
@en
Sven Pörksen
@nl
type
label
Sven Pörksen
@ast
Sven Pörksen
@en
Sven Pörksen
@nl
prefLabel
Sven Pörksen
@ast
Sven Pörksen
@en
Sven Pörksen
@nl
P106
P31
P496
0000-0003-1868-356X